Genzyme Oncology | R&D Pipeline

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript.
You may experience difficulties browsing certain parts of the site.

Genzyme Corporate

Oncology Home

Genzyme Websites

Genzyme Oncology Pipeline

	Research	Preclinical	Phase 1	Phase 2	Phase 3	Postmarketing Studies
ONCOLOGY
Campath chronic lymphocytic leukemia
Clolar pediatric acute lymphocytic leukemia
Clofarabine adult acute myeloid leukemia
GC1008 solid tumors
Clofarabine myelodysplastic syndromes
Tasidotin solid tumors
Clofarabine solid tumors
Topoisomerase I Inhibitors solid tumors